These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20012624)

  • 41. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
    Sämpi M; Ukkola O; Päivänsalo M; Kesäniemi YA; Binder CJ; Hörkkö S
    J Am Coll Cardiol; 2008 Oct; 52(17):1370-8. PubMed ID: 18940525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction.
    Wu R; Nityanand S; Berglund L; Lithell H; Holm G; Lefvert AK
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3159-63. PubMed ID: 9409306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study.
    Ravandi A; Boekholdt SM; Mallat Z; Talmud PJ; Kastelein JJ; Wareham NJ; Miller ER; Benessiano J; Tedgui A; Witztum JL; Khaw KT; Tsimikas S
    J Lipid Res; 2011 Oct; 52(10):1829-36. PubMed ID: 21821825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
    Shoji T; Nishizawa Y; Fukumoto M; Shimamura K; Kimura J; Kanda H; Emoto M; Kawagishi T; Morii H
    Atherosclerosis; 2000 Jan; 148(1):171-7. PubMed ID: 10580183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
    Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
    Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of serum MMP-9 with autoantibodies against oxidized LDL.
    Kalela A; Koivu TA; Höyhtyä M; Jaakkola O; Lehtimäki T; Sillanaukee P; Nikkari ST
    Atherosclerosis; 2002 Jan; 160(1):161-5. PubMed ID: 11755934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of autoimmune antibodies anti-lipoprotein lipase, anti-low density lipoprotein, and anti-oxidized low density lipoprotein on lipid metabolism and atherosclerosis in systemic lupus erythematosus.
    Fesmire J; Wolfson-Reichlin M; Reichlin M
    Rev Bras Reumatol; 2010; 50(5):539-51. PubMed ID: 21125190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study.
    Chen Q; Reis SE; Kammerer C; Craig W; McNamara DM; Holubkov R; Sharaf BL; Sopko G; Pauly DF; Merz CN; Kamboh MI;
    J Lipid Res; 2011 Apr; 52(4):801-7. PubMed ID: 21252261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
    Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
    Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
    Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M
    Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.
    Fredrikson GN; Hedblad B; Berglund G; Alm R; Ares M; Cercek B; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):872-8. PubMed ID: 12649091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
    Ames PR; Matsuura E; Batuca JR; Ciampa A; Lopez LL; Ferrara F; Iannaccone L; Alves JD
    Lupus; 2010 May; 19(6):711-6. PubMed ID: 20064910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.
    Cojocaru IM; Cojocaru M; Burcin C
    Rom J Intern Med; 2006; 44(2):165-70. PubMed ID: 17236297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine.
    Nguyen JT; Myers N; Palaia J; Georgopoulos A; Rubins JB; Janoff EN
    Transl Res; 2007 Sep; 150(3):172-9. PubMed ID: 17761370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The associations of oxidized high-density lipoprotein lipids with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Kresanov P; Ahotupa M; Vasankari T; Kaikkonen J; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
    Free Radic Biol Med; 2013 Dec; 65():1284-1290. PubMed ID: 24095850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE.
    Wu R; Svenungsson E; Gunnarsson I; Andersson B; Lundberg I; Schäfer Elinder L; Frostegård J
    Lupus; 1999; 8(2):142-50. PubMed ID: 10192509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
    J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
    Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.